Curetis is not your typical biotech start-up. We are rather a newcomer with many years of multi-disciplinary expertise. Over the past years we have created a healthy growth story. We have convinced our customers and partners, with our pioneering spirit, coupled with the simple aspiration „We care for Diagnostics“, our engineering prowess, and molecular biology and microbiological expertise.
We are not a typical R&D driven company. We rather put our focus on commercial product development. We listen carefully and flexibly react to market and customer demands and needs. We strive to address these by way of pragmatic and intelligent solutions such as Unyvero.
Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017
MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics
CRIOAC, 3ème Congrès des Centres de Référence des Infections Ostéo-Articulaires Complexes - Tours, France - October, 19 to 20, 2017
Deutscher Kongress für Orthopädie und Unfallchirurgie - Berlin, Germany - October 23 to 27, 2017